Materials And Products Tenders

Open House Biologics Discount Agreements 2024-10 - Pertuzumab / Trastuzumab (Drug Combination)

Open House Biologics Discount Agreements 2024-13 - Somatropin

Medicines with the Active Ingredient Bimekizumab (Atc: L04ac21)

Contract for Special Care for the Implementation of Station-Replacing Services in Accordance with Section 140A Sgb V with the Possibility of Conclusion at any Time as Part of the Open House Procedure

Conclusion of Non-Exclusive Discount Agreements in Accordance with Section 130A Paragraph 8 Sgb V (Open House Model)

Medicines with the Active Ingredient Rituximab - in the Dosage Form Infusion Solution Concentrate (Atc: L01fa01)

Medicines with the Active Ingredient Combination Brinzolamide and Timolol (Atc: S01ed67)

Medicines with the Active Ingredient Sevelamer Hydrochloride (Atc: V03ae02)

Sheet Steel Doors

Medicines with the Active Ingredient Combination Formoterol and Beclometasone (Atc: R03ak08 - with a Potency of 200/6 Micrograms)